Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FJG8T
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,435
Award facts
- Contract value 100% obligated
- $41,434.73 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $41,434.73 delivery order to AmerisourceBergen Drug Corp on January 8, 2026, for the supply of Dupixent 300 mg/2 mL syringes. This non-competitive delivery order utilizes firm fixed pricing and is scheduled for completion by January 9, 2026, with performance taking place at the contractor's Conshohocken, Pennsylvania facility. Dupixent (dupilumab) is a prescription biologic medication commonly used to treat moderate-to-severe atopic dermatitis, eosinophilic esophagitis, and asthma, making this a specialty pharmaceutical supply for federal healthcare needs.
This delivery order is executed under AmerisourceBergen Drug Corp's parent company, Cencora, Inc., which holds a substantial Indefinite Delivery Contract with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031. This prime IDC vehicle enables the delivery of a comprehensive portfolio of pharmaceutical products and medical supplies to support military healthcare programs globally, including medications, vaccines, and medical devices across multiple therapeutic domains. The award reflects the contractor's established capability to supply critical specialty pharmaceuticals to defense and military healthcare systems through an open and competitive federal contracting framework.
Quick answers
Who was awarded contract SPE2DR26FJG8T?
SPE2DR26FJG8T was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26FJG8T worth?
The government has obligated $41,435 on SPE2DR26FJG8T.
Is contract SPE2DR26FJG8T an order under another contract?
Yes. SPE2DR26FJG8T is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJG8T competed?
The extent of competition for SPE2DR26FJG8T was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award